Exploring human biology with N-of-1 clinical trials
Studies on humans that exploit contemporary data-intensive, high-throughput ‘omic’ assay technologies, such as genomics, transcriptomics, proteomics and metabolomics, have unequivocally revealed that humans differ greatly at the molecular level. These differences, which are compounded by each indivi...
Main Authors: | N. J. Schork, B. Beaulieu-Jones, W. S. Liang, S. Smalley, L. H. Goetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Cambridge Prisms: Precision Medicine |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2752614322000151/type/journal_article |
Similar Items
-
Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine
by: Winnie S. Liang, et al.
Published: (2024-03-01) -
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov
by: Paolo Tini, et al.
Published: (2023-04-01) -
Invited review: Maximizing value and minimizing waste in clinical trial research in dairy cattle: Selecting interventions and outcomes to build an evidence base
by: Jan M. Sargeant, et al.
Published: (2022-11-01) -
Managing clustering effects and learning effects in the design and analysis of randomised surgical trials: a review of existing guidance
by: Elizabeth J. Conroy, et al.
Published: (2022-10-01) -
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology
by: Giada Bianchetti, et al.
Published: (2023-09-01)